CBD Oil Market to Hit Nearly US$137 Billion by 2029
The CBD oil market is expected to witness an astounding CAGR of 38.90% from 2021 until 2029, climbing from $9.86 billion to $136.64 billion. There are several reasons behind the projected growth such a growing ... [Read]
CBD Usage Rising in Japan Despite Drug Taboo
Japan may be known for its zero-tolerance cannabis laws and strong social stigma against the drug, but the sentiment towards CBD is quickly changing. CBD extracted from the seeds or adult stems of the plant ... [Read]
Thailand Becomes First Asian Country to Legalize Marijuana
Thailand made headlines last week when it became the first country in Asia to decriminalize marijuana, making it legal to grow and sell or use for medicinal reasons. Thai Health Minister Anutin Charnvirakul expects legal ... [Read]
Cybin Acquires DMT Clinical Study from Entheon Biomedical
Acquisition of largest Phase 1 DMT study conducted to date is expected to accelerate CYB004 program timeline by nine months — — Phase 1 study evaluating pharmacokinetics/pharmacodynamics of DMT currently underway and will inform clinical ... [Read]
Cybin Announces Roster of 28 Expert Faculty and Advisors for its EMBARK Psychedelic Facilitator Training Program
TORONTO — Cybin Inc. (NYSEAMERICAN:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today announced the team of 28 esteemed faculty and advisors who will lead the Company’s EMBARK ... [Read]
Booming Legal Cannabis Market to Continue Rising in 2022 and Beyond
The global cannabis market is continuing to grow rapidly thanks to increasing legalization and social adoption across the globe. According to a report by Vantage Market Research, revenue came in at US$12.8 billion in 2021 ... [Read]
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of approval from Health Canada for medical purposes. Canada’s legislation now permits the use of psychedelics beyond palliative care, something health ... [Read]
Akorn Stock Boosted Over 10% Following FDA Approval
Akorn Inc (NASDAQ:AKRX) has received FDA approval for a nasal spray aimed at treating allergies, boosting Akorn stock over 10%. Akorn is a leading specialty generic pharmaceutical company based in Amityville, New York that develops, manufactures, and ... [Read]